The small molecule inhibitor YK-4-279 disrupts mitotic progression of neuroblastoma cells, overcomes drug resistance and synergizes with inhibitors of mitosis. (2017)
Attributed to:
Understanding and targeting chromatin-surveillance mechanisms in human ageing
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.canlet.2017.05.027
PubMed Identifier: 28602975
Publication URI: http://europepmc.org/abstract/MED/28602975
Type: Journal Article/Review
Volume: 403
Parent Publication: Cancer letters
ISSN: 0304-3835